QWQingsong Wu

Qingsong Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qingsong Wu has a total of 82 co-authors. Here are the top co-authors by number of shared publications:

  • Liangwan Chen

    Department of Cardiac Surgery, Fujian Medical University Union Hospital

    10 shared publications
  • Zhihuang Qiu

    Department of Cardiovascular Surgery Fujian Medical University Union Hospital Fuzhou China

    7 shared publications
  • Linfeng Xie

    Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, Fuzhou, People’s Republic of China

    6 shared publications
  • Xinfan Lin

    Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China; Fujian Medical University, Fuzhou, Fujian, China

    5 shared publications
  • Yue Shen

    Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, Fuzhou, China

    4 shared publications
  • Jian He

    Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, China

    3 shared publications

Latest Publications

  • Open Access

    Application of Non-Invasive Cardiac Output Monitoring in Enhanced Recovery After Surgery for Patients With Acute Type A Aortic Dissection

    by Jian Zheng, Xiangkun Xiao, Ziheng Ye, Lin Huang, Meng Rui, Yiwen Lin, Fuhua Qiu, Lei Sun, Qingsong Wu

    Background: To assess the clinical value of non-invasive cardiac output monitoring (NICOM) within an enhanced recovery after surgery (ERAS) protocol for patients undergoing acute type A aortic dissection (ATAAD) repair. Methods: This study included 242 patients who underwent total arch replacement for ATAAD between January 2024 and June 2025. Patients were stratified into two groups based on postoperative NICOM use (NICOM group, n = 141; control group, n = 101). This study compared hemodynamic parameters, 6-minute walk test (6MWT) results, postoperative recovery, and complications. Results: Baseline characteristics were similar between groups. While 30-day mortality and ventilator time were comparable, the NICOM group demonstrated significantly superior outcomes inintensive care unit (ICU) stays [3.0 (2.0–5.0) vs. 5.0 (3.0–8.0) days; p < 0.001] and hospitalization time [16.0 (11.0–21.0) vs. 19.0 (14.0–23.0) days; p = 0.001]. The NICOM group also showed lower unadjusted rates of reintubation (1.4% vs. 7.9%; p = 0.029), ICU readmission (2.1% vs. 8.9%; p = 0.036), shock (0.7% vs. 5.9%; p = 0.045), and acute heart failure (2.1% vs. 9.9%; p = 0.018), as well as a longer 6MWT distance at discharge [488.0 (433.0–532.0) vs. 457.0 (410.0–521.0) meters; p = 0.02]. However, after applying Bonferroni correction for multiple comparisons, only ICU stay and hospitalization time remained statistically significant; the differences in re‑intubation, ICU readmission, shock, acute heart failure, and 6MWT did not meet the corrected significance threshold. Conclusion: Integrating NICOM into the postoperative care of patients with ATAAD provides reliable, continuous hemodynamic data that facilitate precise, individualized management. This approach stabilizes circulation, reduces key complications, accelerates recovery, and improves perioperative outcomes, underscoring the vital role of this method in implementing ERAS protocols in cardiac surgery.

  • Open Access

    Value of Thromboelastography as a Predictor of Postoperative Acute Respiratory Distress Syndrome in Patients With Acute Type A Aortic Dissection

    by Xiujuan Wang, Kailong Ye, Xingfeng Chen, Yurou Guo, Beiran You, Zhihuang Qiu, Qingsong Wu

    Background: This study aimed to evaluate the effectiveness of thromboelastography (TEG) in predicting postoperative acute respiratory distress syndrome (ARDS) in patients with acute type A aortic dissection (ATAAD). Methods: This retrospective cohort study included 350 consecutive patients with ATAAD who underwent emergency total aortic arch replacement surgery at our institution. Patients were divided into ARDS and non-ARDS groups based on the postoperative development of ARDS. Perioperative data were collected and compared between groups. Results: Overall, 56/350 (16.0%) patients developed postoperative ARDS, of whom four required reintubation and four progressed to respiratory failure. Although 30-day mortality was similar between the ARDS and non-ARDS groups (8.9% vs. 4.1%; p = 0.227), postoperative complications were more complex and severe in the ARDS group. Indeed, this group had longer ventilator use (p = 0.009), a higher incidence of severe pneumonia (p = 0.026), longer intensive care stays (p = 0.019), and more frequent respiratory failure (p = 0.096) and multiple organ failure (p = 0.040). Multivariate analysis identified preoperative clot angle (odds ratio (OR) 4.421, 95% confidence interval (CI) 1.922–8.743; p < 0.001), fibrinogen level (OR 4.473, 95% CI 2.678–9.399; p < 0.001), maximum amplitude (MA) (OR 4.552, 95% CI 2.089–8.947; p < 0.001), cardiopulmonary bypass time (OR 2.796, 95% CI 1.166–6.705; p = 0.021), and intraoperative plasma transfusion (OR 4.057, 95% CI 1.700–9.046; p = 0.004) as independent predictors of postoperative ARDS. The optimal cut-off values for preoperative fibrinogen level, clot angle, and platelet function (MA) on the receiver operating characteristic (ROC) curve analysis were 2.65 μg/mL, 59.4 degrees, and 64.1 mm, respectively, with corresponding areas under the curve of 0.744, 0.781, and 0.807 (all p < 0.001). Conclusion: Preoperative fibrinogen, clot angle, and MA may be useful predictors of postoperative ARDS in patients with ATAAD. TEG enables rapid preoperative assessment of coagulation system status, guiding fibrinogen supplementation and blood transfusion strategies to reduce the incidence of postoperative ARDS and shorten the duration of postoperative mechanical ventilation. Thus, TEG may be a valuable tool for real-time monitoring and improving postoperative outcomes in this population.

  • Open Access

    Long-Term Outcomes of Stent Extension in Thoracic Endovascular Aortic Repair for Type B Aortic Dissection

    by Qingsong Wu, Kailong Ye, Siying Luo, Xinfan Lin, Xiaolong Ye, Zhisheng Wang, Xuchao Liu, Xiangkun Xiao, Lin Huang, Liangwan Chen, et al.


  • Open Access

    Validation of the GERAADA Score for Predicting 30‐Day Mortality Rate in Acute Type A Aortic Dissection: A Single‐Center Study in China

    by Xin‐Fan Lin, Hang‐Qi Gao, Qing‐Song Wu, Yu‐Ling Xie, Liang‐Wan Chen, Lin‐Feng Xie

    Background: This study aimed to validate the predictive performance of the GERAADA (German Registry for Acute Type A Aortic Dissection) score in predicting 30‐day mortality rate in patients with acute type A aortic dissection in China. Methods: We retrospectively analyzed 526 patients who underwent surgical treatment for acute type A aortic dissection at our institution between 2018 and 2021. The predictive performance of the GERAADA score was evaluated using calibration (observed‐to‐expected ratio and Hosmer–Lemeshow test) and discrimination (area under the receiver operating characteristic curve). Logistic regression analysis was performed to identify risk factors of 30‐day mortality rate. Stratified analyses were conducted to assess performance across different risk categories. Results: The cohort exhibited distinct characteristics, including younger age, longer intervals from onset to admission, and more extensive aortic arch procedures. The GERAADA score demonstrated good calibration (Hosmer–Lemeshow test, P =0.461) and discriminative power (area under the receiver operating characteristic curve=0.863). Low‐risk patients (score <20; 78.7% of cohort) had a mortality rate of 2.4%, while high‐risk patients (score ≥20) showed mortality rates aligning with predicted values (observed‐to‐expected ratio=1.2). Patients with preoperative critical conditions or end‐organ malperfusion exhibited a significantly higher mortality rate. Furthermore, we identified independent risk factors beyond the GERAADA scoring system, and these factors exhibited significant differences between high‐ and low‐risk patients. To address these findings, we developed a mortality risk assessment strategy based on GERAADA score, which further stratifies patients according to their specific clinical characteristics, serving as an optimization and expansion of the GERAADA score. Conclusions: This study validated the GERAADA score in China for predicting mortality risk in patients with acute type A aortic dissection, showing strong performance in discrimination and calibration. We also developed a mortality risk assessment strategy based on the GERAADA score, offering a practical framework for clinical use. The modular design allows for easy adaptation across centers, although further multicenter studies are needed to confirm its generalizability.


  • Open Access

    Predictive role of serum sST2 for heart failure in children with severe pneumonia

    by Qingsong Wu, Xinxin Zheng, Xinfan Lin, Linfeng Xie, Liangwan Chen, Zhihuang Qiu

    To evaluate the predictive value of soluble suppression of tumorigenesis-2 (sST2) for heart failure (HF) in children hospitalized with severe pneumonia. A total of 109 children with severe pneumonia who were admitted to our hospital between January 2022 and December 2023 were selected. They were divided into HF and non-HF groups based on whether they developed HF. Clinical characteristics and clinical outcome data of the two groups were analyzed using relative factors analysis and logistic regression analysis. The HF and non-HF groups consisted of 35 and 74 patients, respectively. Significant differences were observed between the groups in terms of age [20.0 (11.0–38.0) vs. 60.0 (36.0–96.0) months, P < 0.001], body mass index (16.7 ± 2.0 vs. 18.3 ± 2.5 kg/m2, P < 0.001), and body surface area (0.52 ± 0.13 vs. 0.75 ± 0.23 m2, P < 0.001), with all values being lower in the HF group as compared to the non-HF group. Serum levels of sST2 (7.01 ± 2.31 vs. 4.38 ± 1.65 ng/mL, P < 0.001) and NT-proBNP [86.0 (78.5–108.5) vs. 65.0 (25.0–83.0) pg/mL, P < 0.001] were significantly higher in the HF group. The incidence of type I respiratory failure was also significantly higher in the HF group as compared to the non-HF group (45.7% vs. 25.7%, P = 0.005). Univariate logistic regression analysis revealed that age, body surface area, body mass index, type I respiratory failure, C-reactive protein level, NT-proBNP level, and sST2 level were significant risk factors for HF in children with severe pneumonia. Multivariate analysis identified sST2 levels > 5.84 ng/mL as an independent risk factor for HF [odds ratio (OR) = 3.974, 95% confidence interval (CI) 1.266–12.323, P = 0.003], with an area under the curve (AUC) of 0.828 (95% CI 0.718–0.927), sensitivity of 89.3%, and specificity of 78.8%. Elevated sST2 shows potential as an independent risk factor for HF in children with severe pneumonia, but further studies are needed before routine clinical adoption.


  • Open Access

    Ursodeoxycholic acid alleviates aortic aneurysm and dissection through the intestinal farnesoid X receptor/ceramide synthase 2 axis

    by Zhaofeng Zhang, Linfeng Xie, Xinfan Lin, Jian He, Yuling Xie, Jiakang Li, Xinghui Zhuang, Lele Tang, Rumei Xie, Qingsong Wu, et al.

    Aortic aneurysm and dissection (AAD) are severe cardiovascular conditions that carry significant risks and currently lack an effective treatment. Ursodeoxycholic acid (UDCA) can delay the onset of various metabolic diseases such as type 2 diabetes and obesity. However, it remains unclear whether UDCA can delay the onset of AAD. We demonstrated pathological activation of the intestinal Farnesoid X receptor (FXR) in both AAD patients and AAD mice. UDCA significantly suppressed intestinal FXR activation. In vivo experiments demonstrated that knockdown of intestinal FXR in mice using adeno-associated virus (AAV) reduced the incidence of AAD, reduced macrophage infiltration, and improved extracellular matrix degradation. In vitro experiments demonstrated that activating intestinal FXR increases the expression of ceramide synthase 2 (Cers2), which participates in the de novo synthesis of ceramides, and promotes the release of C20 ceramide. C20 ceramide promotes extracellular matrix metalloproteinases (MMPs) release from macrophages, leading to extracellular matrix degradation and contributing to AAD development. Our findings highlight the role of UDCA in reducing AAD incidence, revealing the therapeutic potential of the intestinal FXR/Cers2 axis against AAD.


  • Open Access

    Hepatic Abnormal Secretion of Apolipoprotein C3 Promotes Inflammation in Aortic Dissection

    by Xinghui Zhuang, Mohammad Zarif, Yue Shen, Zhaofeng Zhang, Jian He, Linfeng Xie, Qingsong Wu, Xinfan Lin, Keyuan Chen, Yue Tian, et al.

    Background: Apolipoprotein C3 (apo C3) is primarily secreted by the liver and is involved in promoting sterile inflammation and organ damage under pathological conditions. Previous studies have shown that apo C3 is abundant in the plasma exosomes of patients with aortic dissection (AD), but its specific role in AD remains unclear. Methods and Results: In vivo, adeno‐associated virus was used to knock down hepatic apo C3 expression in an AD mouse model to assess the impact of liver‐derived apo C3 on the development of AD. In vitro, recombinant apo C3 protein was added to the culture medium of J774A.1 macrophages to evaluate its effect on macrophage polarization and to identify the underlying mechanisms. Additionally, the effect of apo C3 on the function of aortic endothelial and smooth muscle cells was explored. Apo C3 in the aortas of AD mice was found to originate from abnormal hepatic secretion, which enters the bloodstream and subsequently deposits in the aorta. Adeno‐associated virus–mediated hepatic apo C3 knockdown significantly reduced AD incidence ( P =0.0036), macrophage infiltration ( P =0.0004), and collagen deposition in the aorta ( P =0.0016). Similarly, inhibiting the apo C3 receptor Toll‐like receptor 2 significantly lowered AD incidence ( P =0.0352). In vitro, recombinant apo C3 protein promoted M1 polarization and matrix metalloproteinase secretion in macrophages by activating the Toll‐like receptor 2/NLR family pyrin domain containing 3 pathway. Additionally, apo C3 increased adhesion molecule expression in endothelial cells and induced inflammation, chemotaxis, and apoptosis in vascular smooth muscle cells. Conclusions: Our findings highlight the role of abnormally secreted hepatic apo C3 in promoting aortic inflammation.


  • Open Access

    Prediction of Postoperative Acute Kidney Injury Risk Factors for Acute Type A Aortic Dissection Patients after Modified Triple-Branched Stent Graft Implantation by a Perioperative Nomogram: A Retrospective Study

    by Fan Xu, Linfeng Xie, Jian He, Qingsong Wu, Xinfan Lin, Yunnan Hu, Liangwan Chen

    Objective. Predicting risk factors for acute kidney injury (AKI) after total arch replacement via modified triple-branched stent graft (MTBSG) implantation in patients with acute type A aortic dissection (AAAD) by conducting a nomogram. Methods. We collected the clinical data of 254 patients with AAAD who underwent MTBSG implantation surgery in our center. The independent risk factors of postoperative AKI were screened by univariate and multivariate logistic regression analysis and combined into a nomogram. We use receiver operating characteristic (ROC) curves, decision curve analysis (DCA), clinical impact curve (CIC), and calibration plots to evaluate the accuracy of the nomogram model. Results. Multiple logistic regression analysis showed that the risk factors of AKI after MTBSG implantation were age, malperfusion syndrome, preoperative serum creatinine, cardiopulmonary bypass time, and amount of red blood cell (RBC) transfusion. Based on these five risk factors, we established a nomogram model. The good accuracy and clinical applicability of the model were verified by drawing ROC curve (area under the curve (AUC)=0.854), DCA curve, CIC curve, and calibration curve. Conclusions. Using perioperative clinical data to establish a nomogram model of AKI in patients with AAAD who received MTBSG implantation can be used as a tool to predict the occurrence of AKI after operation.


  • Open Access

    A new procedure for elimination of atrial fibrillation associated with mitral valve disease: a proof-of-concept study

    by Liangwan Chen, Qianzhen Li, Junyi Chen, Zhihuang Qiu, Jun Xiao, Mirong Tang, Qingsong Wu, Yue Shen, Xiaofu Dai, Guanhua Fang, et al.

    Background: Left atrial enlargement and fibrosis have been linked to the pathogenesis of atrial fibrillation (AF). The authors aimed to introduce a novel concept and develop a new procedure for AF treatment based on these characteristics. Methods: The study included three stages. The first stage was a descriptive study to clarify the characteristics of the left atrial enlargement and fibrosis’ distribution in patients with mitral valve disease and long-standing persistent AF. Based on these characteristics, the authors introduced a novel concept for AF treatment, and then translated it into a new procedure. The second stage was a proof-of-concept study with this new procedure. The third stage was a comparative effectiveness research to compare the clinical outcomes between patients with this new procedure and those who received Cox-Maze IV treatment. Results: Based on the nonuniform fashion of left atrial enlargement and fibrosis’ distribution, the authors introduced a novel concept: reconstructing a left atrium with appropriate geometry and uniform fibrosis’ distribution for proper cardiac conduction, and translated it into a new procedure: left atrial geometric volume reduction combined with left appendage base closure. As compared to the Cox-Maze IV procedure, the new procedure spent significantly shorter total surgery time, cardiopulmonary bypass time, and aortic cross-clamp time (P<0.001). Besides, the new procedure was related to a shorter ICU stay period (odd ratio (OR)=0.45, 95% CI=0.26–0.78), lower costs (OR=0.15, 95% CI=0.08–0.29), and a higher rate of A wave of transmitral and transtricuspid flow reappearance (OR=1.76, 95% CI=1.02–3.04). Conclusions: The new procedure is safe and effective for eliminating AF associated with mitral valve disease.